Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposi's sarcoma

AIDS

Volumn 10, Issue 7, 1996, Pages 753-757

  Girard, Pierre Marie ^a   Bouchaud, Olivier ^b   Goetschel, Agnès ^a   Mukwaya, Geoffrey ^c,d   Eestermans, Gerald ^c,d   Ross, Michael ^c,d   Rozenbaum, Willy ^a   Saimot, Adrien Gérard ^b  

^a HÔPITAL ROTHSCHILD   (France)

^b BICHAT HOSPITAL   (France)

^c GILEAD SCIENCES   (United States)

^d NeXstar Pharmaceuticals Inc   (Belgium)

Author keywords

AIDS; Kaposi's sarcoma; Liposomal daunorubicin

Indexed keywords

ANTIINFECTIVE AGENT; DAUNORUBICIN; LIPOSOME;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALLERGIC REACTION; ANOREXIA; ANXIETY; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COUGHING; DEPRESSION; DIARRHEA; DISEASE COURSE; DRUG DELIVERY SYSTEM; DYSPNEA; FATIGUE; FEVER; GRANULOCYTOPENIA; HUMAN; INSOMNIA; INTRAVENOUS DRUG ADMINISTRATION; KAPOSI SARCOMA; MALE; MULTICENTER STUDY; NAUSEA; PHARMACEUTICS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PRURITUS; SWEATING;

EID: 0029984056     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199606001-00009     Document Type: Article

References (19)

1. Centers for Disease Control: HIV/AIDS Surveillance Report. Atlanta: CDC; January 1990.
2. Meduri GU, Stover DE, Lee M, et al.: Pulmonary Kaposi's sarcoma in the acquired immune deficiency syndrome: clinical, radiographic and pathologic manifestations. Am J Med 1986, 81:11-18.
3. Hoover DR, Black C, Jacobson LP, et al.: Epidemiologic analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual men. Am J Epidemiol 1993, 138:266-278.
4. Lassoued K, Clauvel JP, Katlama C, et al.: Treatment of the acquired immune deficiency syndrome-related Kaposi's sarcoma with bleomycin as a single agent. Cancer 1990, 66:1869-1872.
5. Rieber E, Mittelman A, Wormser GP, et al.: Vincristine and Kaposi's sarcoma in the acquired immunodeficiency syndrome [letter]. Ann Intern Med 1984, 101:876.
6. Mintzer DM, Real FX, Jovino L, Krown SE: Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1985, 102:200-202.
7. Volberding P, Abrams DI, Conant M, Kaslow K, Vranizan K, Ziegler J: Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med 1985, 103:335-338.
8. Paredes J, Kahn JO, Tong WP, et al.: Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicentre trial of the AIDS clinical trials group. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 9:138-144.
9. Gill PS, Akil B, Colletti P, et al.: Pulmonary Kaposi's sarcoma: clinical findings and results of therapy. Am J Med 1989, 87:57-61.
10. Shepherd FA, Burkes RL, Paul KE, Goss PE: A phase II study of 4′-epirubicin in the treatment of poor-risk Kaposi's sarcoma and AIDS. AIDS 1991, 5:305-309.
11. Karlowsky JA, Zhanel GG: Concepts on the use of liposomal antimicrobial agents: applications for aminoglycosides. Clin Infect Dis 1992, 15:654-667.
12. Forssen EA, Ross ME: DaunoXome treatment of solid tumors: preclinical and clinical investigations. J Liposome Res 1994, 4:481-512.
13. Presant CA, Scolaro M, Kennedy P, et al.: Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma. Lancet 1993, 341:1242-1243.
14. Money-Kyrle JF, Bates F, Ready J, et al.: Liposomal daunorubicin in advanced Kaposi's sarcoma: a phase II study. Clin Oncol 1993, 5:367-371.
15. Gill PS, Espina BM, Muggia F, et al.: Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol 1995, 13:996-1003.
16. Green S, Weiss GR: Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria. Invest New Drugs 1992, 10:239-253.
17. Bogner JR, Kronawitter V, Rolinski B, et al.: Liposomal doxorubicin in the treatment of advanced AIDS-related Kaposi's sarcoma. J Acquir Immune Defic Syndr 1994, 7:463-468.
18. Simpson JK, Miller RF, Spittle MF: Liposomal doxorubicin for treatment of AIDS-related Kaposi's sarcoma. Clin Oncol 1993, 5:372-374.
19. Gompels MM, Hill A, Jenkins P, et al.: Kaposi's sarcoma in HIV-infection treated with vincristine and bleomycin. AIDS 1992, 6:1175-1180.